Overview

A Cervical Screening Test (CST) has taken the role of the Pap test. The CST detects the presence of HPV. This new CST is a more sensitive and enhanced version of the old Pap test.
The CST is an HPV test, and if HPV positive, the sample is screened for cell alterations automatically. This test is offered exclusively to women.
In December 2017, Medicare eligibility standards for Cervical Screening Tests changed.
Some women may be ineligible for a Medicare-rebatable cervical screening test if they are above the screening age (25Y - 74Y) or come for a re-test sooner than advised. This might result in a pathology charge from the pathology provider.

What to expect

In a 30-minute appointment, we’ll begin with explaining the purpose of CST and what the procedure involves.

You will be asked to lie on an examination table with your knees bent so we can gently insert a speculum into your vagina to inspect your cervix. Using a soft brush or spatula, we will collect a sample of cells from the cervix; this is quick but may cause mild discomfort or pressure. The sample will be sent off for lab analysis. We will let you know when and how you will receive the results of your test.

Frequently Asked Questions